Boston, Massachusetts
March 4–7, 2018


Preliminary Agenda

The CROI Program and Information Guide, including all session and presentations, will be posted on CROI website 1 week prior to CROI.

Sunday, March 4, 2018

9:00 AM

  • Program Committee Workshops for Young Investigators and Trainees
    Conveners: Serena S. Spudich, Yale University, and John W. Mellors, University of Pittsburgh

    Animation of the HIV Life Cycle
    Janet Iwasa, University of Utah

    Advances in Molecular Virology
    Frank Kirchhoff, Ulm University Medical Center

    Advances in Immunology
    Alexandra Trkola, University of Zurich

    Advances in Tuberculosis Treatment and Prevention
    Richard E. Chaisson, The Johns Hopkins University

    Advances in HIV Prevention

    Wafaa M. El-Sadr, ICAP at Columbia University

    Advances in HIV Cure
    Huldrych F. Günthard, University of Zurich

  • Martin Delaney Presentation on Women in Research: Science is Better When Women Are Represented
    Moderator: Lisa Diane White, SisterLove, Inc

    Panelists: Dázon Dixon Diallo, SisterLove, Inc, Tonia Poteat, The Johns Hopkins University

    Women as Activists in Research
    Dázon Dizon Diallo, SisterLove, Inc

    Perspective of Women Conducting Research
    Tonia Poteat, The Johns Hopkins University

    International Perspective of Representation of Women in Research
    Speaker to be determined

2:00 PM

Concurrent Workshops

  • Clinical Trial Design and Analysis Workshop
    Conveners: Susan P. Buchbinder, San Francisco Department of Public Health, and Richard E. Chaisson, The Johns Hopkins University

    Seeing the Forest Through the Trees: Using Phylogenetics to Impact the Epidemic
    Susan J. Little, University of California San Diego

    Measuring Population-Level Impact of Interventions
    Jessica E. Justman, Columbia University

    Pragmatic Trials
    Alison Grant, London School of Hygiene & Tropical Medicine

  • Frontiers in Laboratory Science Workshop
    Conveners: Galit Alter, Ragon Institute of MGH, MIT and Harvard, and Frank Kirchhoff, Ulm University Medical Center

    Virus-Like Nanocarriers for Transfer of Cargoes Between Cells
    Joerg Votteler, University of Utah

    3D and Multi-Scale Imaging of HIV-1 Spread in Tissues
    Pamela Bjorkman, California Institute of Technology

    Single Cell Viral and Receptor Bar Codes: Beyond the Single Cell Transcriptome
    Eli A. Boritz, NIAID

    Synthetic RNA Vaccines

  • Interactive Case-Based Workshop on Hepatitis C
    Conveners: Debika Bhattacharya, University of California Los Angeles, and Arthur Kim, Harvard University

    Acute HCV Infection With Reinfection
    Christop Boesecke, University of Bonn

    HCV Resistance and Retreatment
    Pablo Ryan, Hospital Universitario Infanta Leonor

    HCV Prevention and Treatment in Children
    Ravi Jhaveri, University of North Carolina Chapel HIll

    Steatosis: Testing and Treatment
    Kathleen Corey, Harvard University

5:00 PM

Opening Session

  • Bernard Fields Lecture
    Julie M. Overbaugh, Fred Hutchinson Cancer Research Center

  • N’Galy-Mann Lecture
    Elizabeth A. Bukusi, Kenya Medical Research Institute

    A performance of personal testimonies, dance, music, and song

7:00 PM

Welcome Reception

Monday, March 5, 2018

8:30 AM

Plenary Session 1:
A Retrospective of the HIV Epidemic and a Focus on New Challenges
Harold W. Jaffe, Centers for Disease Control and Prevention

Pathogenesis of Tuberculosis and Vaccine Prevention
JoAnne L. Flynn, University of Pittsburgh

10:00 AM

Concurrent Oral Abstract Sessions

12:00 PM Lunch Break
1:30 PM

Concurrent Themed Discussions

2:30 PM Poster Abstract Sessions

4:00 PM

Concurrent Symposia

  • Stop It Now: Targeting Early Infection Events
    Conveners: Brandon Keele, National Cancer Institute, and Michaela Müller-Trutwin, Institute Pasteur

    Mechanism of Early CD8+ T-Cell Control
    Jonah Sacha, Oregon Health and Sciences University

    Early Broadly Neutralizing Antibody Treatment Leading to T-Cell Control
    Malcolm Martin, NIAID

    Anti-Alpha-4/Beta-7 Antibody-Mediated Control: Understanding the Mechanism
    James Arthos, NIAID

    Early Intervention Therapies in Humans: ART, Antibodies, and Vaccines
    Eugène Kroon, SEARCH, The Thai Red Cross AIDS Research Centre

  • Breast Is Best, but It's a Viral Milkshake!
    Conveners: Ruth Nduati, University of Nairobi, and Phillipe Van De Perre, L'Université de Montpellier

    The Infant Gut: A Great Defense System
    Andrew Prendergast, Queen Mary University of London

    Breast Feeding and the Oncogenic Risk of HTLV-1
    Antoine Gessain, Institute Pasteur

    ART in Breast Milk – Does It Add Value?
    Catriona Waitt, University of Liverpool

    Can We Eliminate Breast Milk Transmission of HIV?
    Ameena Goga, South African Medical Research Council

  • Obstacles to the Global Control of Tuberculosis
    Conveners: David Alland, University of Medicine and Dentistry of New Jersey, and Mina Hosseinipour, University of North Carolina Project–Malawi

    The Global Burden of TB and Modeling Control Strategies
    Nimalan Arinaminpathy, Imperial College London

    Using Whole Genome Sequencing to Better Understand TB Transmission Dynamics
    Neel Gandhi, Emory University

    Underdiagnosed TB and Its Role in TB Transmission
    Neil Martinson, Chris Hani Baragwanath Hospital

    New Developments in the Management of Drug-Resistant TB Disease
    Serena Koenig, Harvard University

  • Strategies for Improving the US Care Cascade: Confronting a Fragmented Health System
    Conveners: Ank E. Nijhawan, University of Texas Southwestern, and Darrell Wheeler, University at Albany

    The Evolving US HIV Epidemic
    Carlos del Rio, Emory University

    HIV Testing: The Gateway to Care and Prevention
    Hyman Scott, San Francisco Department of Public Health

    Systems of Care for Vulnerable Populations in the US
    Julie Dombrowski, University of Washington

    Providing Care in Under-Resourced US Communities
    Michael Mugavero, University of Alabama at Birmingham

Tuesday, March 6, 2018

8:30 AM

Plenary Session 2:
The Vaginal Microbiome and the Acquisition of HIV Infection
Nichole R. Klatt, University of Washington

Issues of Mental Health in Patients With or at Risk for HIV Infection
Robert H. Remien, New York State Psychiatric Institute

10:00 AM

Concurrent Oral Abstract Sessions

12:00 PM Lunch Break
1:30 PM

Concurrent Themed Discussions

2:30 PM Poster Abstract Sessions

4:00 PM

Concurrent Symposia

  • Molecular Machines
    Conveners: Zandrea Ambrose, University of Pittsburgh, and Bing Chen, Harvard University

    HIV Env: Structure and Function
    Peter D. Kwong, Vaccine Research Center, NIAID

    HIV-1 Reverse Transcriptase Initiation Complex
    Elisabetta Viani Puglisi, Stanford University

    SamHD1: Structure and Function
    Ian Taylor, The Francis Crick Institute

    Vps4 ATPase: Structure and Mechanism
    Christopher P. Hill, University of Utah

  • Life Expectancy at 25
    Conveners: Peter W. Hunt, University of California San Francisco, and Dominique Costagliola, INSERM

    Epidemiology of Morbidity and Mortality in the Modern ART Era
    Caroline Sabin, University College London

    Role of Noninfectious Risk Factors in Morbidity and Mortality
    Keri Althoff, The Johns Hopkins University

    Role of Inflammation on Morbidity and Mortality
    Jason V. Baker, University of Minnesota

    Moderated Discussion with Audience
    Peter W. Hunt, University of California San Francisco

  • PrEP Works, Now What?
    Conveners: Elizabeth M. Irungu, Kenya Medical Research Institute , Leandro Mena, University of Mississippi Medical Center

    Intersection of PrEP and STIs
    Julia A. Schillinger, New York City Department of Health and Mental Hygiene

    Impact of PrEP on the Incidence of HIV
    Roel Coutinho, University Medical Center Utrecht

    Five Controversies in ART Scale-Up
    Linda-Gail Bekker, Desmond Tutu HIV Foundation

    Kenya: Taking the Leap in Scale-Up
    Nelly Mugo, Kenya Medical Research Institute

Wednesday, March 7, 2018

8:30 AM

Plenary Session 3:
Growing up With HIV: Adolescence to Adulthood
Patricia M. Flynn, St Jude Childen's Research Hospital

UNAIDS 90-90-90 Scale-Up for HIV Treatment
Helen Weiss, London School of Hygiene and Tropical Medicine

10:00 AM

Concurrent Oral Abstract Sessions

12:00 PM Lunch Break
1:30 PM

Concurrent Themed Discussions

2:30 PM Poster Abstract Sessions

4:00 PM

Concurrent Symposia

  • ART: The Next 25 Years
    This symposium is dedicated to the memory of Dr Mark A. Wainberg

    Conveners: Eric Arts, Western University, and Marta Boffito, Chelsea and Westminster NHS Foundation Trust

    Integrating New Antiretroviral Therapies
    Chloe Orkin, Barts Health NHS Trust

    Neutralizing Antibodies for HIV Treatment and Prevention: Dream or Pipe Dream
    Daniel Kuritzkes, Harvard University

    ART Strategies, Including Long-Acting Therapies, Across the Pediatric Spectrum
    Helena Rabie, Stellenbosch University

  • Emerging Priorities in Liver Disease
    Conveners: Benjamin Linas, Boston, University, and Gail Matthews, Kirby Institute

    The Opioid Epidemic and Infectious Diseases: A Public Health Crisis
    Sally Hodder, West Virginia Clinical and Translational Science Institute

    Global Elimination of Hepatitis C
    Jordan Feld, Toronto General Hospital

    The Rising Challenge of Liver Cancer
    Massimo Colombo, University of Milan

    Transplantation of HIV- and HCV-Infected Organs
    Christine Durand, The Johns Hopkins University